DORAVIRINE
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
BACKGROUND
Doravirine (DOR) demonstrated noninferior efficacy to darunavir plus ritonavir (DRV+r) and efavirenz (EFV) in 2…
Doravirine is a non-nucleoside reverse transcriptase inhibitor indicated for the treatment of human immunodeficiency virus-1…
Doravirine is a nonnucleoside reverse transcriptase inhibitor that has been approved for the treatment of HIV-1. In a phase 1…
Abstract Background Doravirine (DOR) is a novel non-nucleoside reverse-transcriptase inhibitor (NNRTI). In the phase 3 DRIVE…
Over the past 30 years, antiretroviral drug regimens for treating HIV infection have become more effective, safer, and more…
Abstract Background Doravirine is a novel, non-nucleoside reverse-transcriptase inhibitor (NNRTI) that has demonstrated efficacy…
World Health Organization estimates that 34 million individuals globally are living with Human Immunodeficiency Virus (HIV…
Weight-Adjusted LNG Concentrations Weight was a predictor of LNG concentrations (1kg increase in weight = 5pg/mL decrease in LNG…
Currently there are 28 approved antiretroviral drugs in six mechanistic classes, and recommended first‐line regimens are highly…